• Clinical Trial of Human Normal Immunoglobulin to Prevent Infections in Patients with Secondary Antibody Deficiency due to CLL, Multiple Myeloma or Non‑Hodgkin Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Italy Poland Spain

  • A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Poland Spain +1

  • Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Poland Portugal Spain

  • Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Greece Italy Poland +1

  • Efficacy and safety of lutetium‑177 vipivotide tetraxetan with gozetotide in patients with progressive adenoid cystic carcinoma of the salivary glands

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Greece Italy The Netherlands +3

  • Study of dienogest and drospirenone on ovulation inhibition for pregnancy prevention in healthy premenopausal women

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Germany

  • Immune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain

  • Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Norway Sweden

  • Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    Czechia Denmark France Germany Greece Italy +3

powered by